MRC1 and neoplasm: We have recently applied this nanobody for site-specific modification and conjugation to a customizable nanogel drug carrier platform, which then promoted effective nanoparticle delivery to MMR-expressing TAMs in vitro, ex vivo, and in vivo of tumor-bearing mice [34].